Reaction Details |
| Report a problem with these data |
Target | Cytochrome P450 3A4 |
---|
Ligand | BDBM50185916 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEMBL_351820 (CHEMBL867803) |
---|
IC50 | >10000±n/a nM |
---|
Citation | Ghosh, S; Elder, A; Guo, J; Mani, U; Patane, M; Carson, K; Ye, Q; Bennett, R; Chi, S; Jenkins, T; Guan, B; Kolbeck, R; Smith, S; Zhang, C; LaRosa, G; Jaffee, B; Yang, H; Eddy, P; Lu, C; Uttamsingh, V; Horlick, R; Harriman, G; Flynn, D Design, synthesis, and progress toward optimization of potent small molecule antagonists of CC chemokine receptor 8 (CCR8). J Med Chem49:2669-72 (2006) [PubMed] Article |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Cytochrome P450 3A4 |
---|
Name: | Cytochrome P450 3A4 |
Synonyms: | Albendazole monooxygenase | Albendazole sulfoxidase | CP3A4_HUMAN | CYP3A3 | CYP3A4 | CYPIIIA3 | CYPIIIA4 | Cytochrome P450 3A3 | Cytochrome P450 3A4 (CYP3A4) | Cytochrome P450 HLp | Nifedipine oxidase | Quinine 3-monooxygenase | Taurochenodeoxycholate 6-alpha-hydroxylase |
Type: | Enzyme |
Mol. Mass.: | 57349.57 |
Organism: | Homo sapiens (Human) |
Description: | n/a |
Residue: | 503 |
Sequence: | MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMF
DMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISI
AEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYS
MDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICV
FPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSI
IFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVV
NETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFS
KKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLG
GLLQPEKPVVLKVESRDGTVSGA
|
|
|
BDBM50185916 |
---|
n/a |
---|
Name | BDBM50185916 |
Synonyms: | 1-(3-phenoxy-benzyl)-piperidine-4-carboxylic acid ethylamide | CHEMBL205304 |
Type | Small organic molecule |
Emp. Form. | C21H26N2O2 |
Mol. Mass. | 338.4433 |
SMILES | CCNC(=O)C1CCN(Cc2cccc(Oc3ccccc3)c2)CC1 |
Structure |
|